Association of BsmI variant of vitamin D receptor gene with polycystic ovary syndrome: A case-control study


Background: Polycystic ovarian syndrome (PCOS) is an endocrine disorder that affects women’s fertility and causes alterations such as obesity, insulin resistance, menstrual irregularities, and polycystic ovaries. The results of the studies show that the issue of vitamin D and vitamin D receptor (VDR) is controversial for PCOS susceptibility.

Objective: To investigate the association of BsmI polymorphism in the VDR gene with metabolic parameters in obese PCOS women.

Materials and Methods: In this case-control study, 38 obese subjects with PCOS and 40 unrelated obese individuals were evaluated to determine the allelic and genotypic frequency of BsmI variant by Polymerase Chain Reaction Restriction Fragment Length Polymorphism method. Body Mass Index, parathyroid hormone, phosphorus, and calcium were evaluated in all participants.

Results: BsmI (rs1544410), (A/G) AA, AG, GG, A, and G percentage of genotypic/allelic frequencies were 65.8, 26.3, 7.9, 78.9, and 21.1 in cases and 57.5, 40, 2.5, 77.5, and 22.5 in controls, respectively. Statistical analysis revealed that the differences in genotypic (p = 0.31)/allelic (p = 0.83) frequencies and dominant (p = 0.45)/recessive (p = 0.35) models between the cases and controls were not significant. This study indicates no association between the BsmI genotypes and metabolic parameters.

Conclusion: It can be concluded that VDR BsmI (rs1544410) Intron 8 (A > G) was not associated with obesity along with PCOS susceptibility in the studied groups.

Key words: Vitamin D receptor, Polycystic ovary syndrome, Genetic association study.

[1] Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril 2009; 92: 1381–1383.

[2] Uitterlinden AG, Fang Y, van Meurs JBJ, van Leeuwen H, Pols HAP. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J Steroid Biochem Mol Biol 2004; 89-90: 187–193.

[3] Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 577–583.

[4] Pimenta dos Reis GVO, Gontijo NA, Rodrigues KF, Alves MT, Ferreira CN, Gomes KB. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review. J Obstet Gynaecol Res 2017; 43: 436– 446.

[5] Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Euro J Endocrinol 2009; 161: 575–582.

[6] Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D3. Endocrinol Metab Clin North Am 2010; 39: 255–269.

[7] Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1alpha, 25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25: 543–559.

[8] Szczepanska M, Mostowska A, Wirstlein P, Skrzypczak J, Misztal M, Jagodzinski PP. Polymorphic variants in vitamin D signaling pathway genes and the risk of endometriosisassociated infertility. Mol Med Rep 2015; 12: 7109–7115.

[9] Mahmoudi T, Majidzadeh K, Farahani H, Mirakhorli M, Dabiri R, Nobakht H, et al. Association of vitamin D receptor gene variants with polycystic ovary syndrome: A case control study. Int J Reprod Biomed 2015; 13: 793– 800.

[10] Siddamalla S, Venkat Reddy T, Govatati S, Erram N, Deenadayal M, Shivaji S, et al. Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in South Indian women. Gynecol Endocrinol 2018; 34: 161– 165.

[11] Bagheri M, Rad IA, Jazani NH, Nanbakhsh F. Lack of association of vitamin D receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) genetic variations with polycystic ovary syndrome risk: A case-control study from Iranian azeri turkish women. Maedica (Buchar) 2012; 7: 303–308.

[12] Pittas AG, Lau J, Hu FB, Dawson-Hughes B. Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 2017–2029.

[13] Ngo DTM, Chan WP, Rajendran S, Heresztyn T, Amarasekera A, Sverdlov AL, et al. Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 2011; 25: 326–330.

[14] Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol 2012; 166: 765–778.

[15] Uitterlinden AG, Fang Y, Van Meurs JBJ, Pols HAP, Van Leeuwen JPTM. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143–156.

[16] Ranjzad F, Mahban A, Shemirani AI, Mahmoudi T, Vahedi M, Nikzamir A, et al. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet 2011; 28: 225–232.

[17] Han FF, Lv YL, Gong LL, Liu H, Wan ZR, Liu LH. VDR gene variation and insulin resistance related diseases. Lipids Health Dis 2017; 16: 157–168.

[18] Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 2011; 164: 741–749.

[19] Jedrzejuk D, Łaczmański Ł, Milewicz A, Kuliczkowska- Płaksej J, Lenarcik-Kabza A, Hirnle L, et al. Classic PCOS phenotype is not associatedwith deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): A case-control study of lower Silesian women. Gynecol Endocrinol 2015; 31: 976–979.

[20] Zadeh-Vakili A, Ramezani Tehrani F, Daneshpour MS, Zarkesh M, Saadat N, Azizi F. Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS. Gene 2013; 515: 193–196.

[21] El-Shal AS, Shalaby SM, Aly NM, Rashad NM, Abdelaziz AM. Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. Mol Biol Rep 2013; 40: 6063–6073.

[22] Lin MW, Tsai SJ, Chou PY, Huang MF, Sun HS, Wu MH. Vitamin D receptor 1a promotor K1521 G/C and K1012 A/G polymorphisms in polycystic ovary syndrome. Taiwan J Obstet Gynecol 2012; 51: 565–571.

[23] Dasgupta S, Dutta J, Annamaneni S, Kudugunti N, Battini MR. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women. Indian J Med Res 2015; 142: 276–285.

[24] Kumar AN, Satyanarayana U, Naidu JN, Ramalingam K, Anitha M. Vitamin D receptor gene polymorphism in obese and non obese indian women with polycystic ovary syndrome. Int J Curr Res 2015; 7:19686–19691.

[25] Tavakkoli M, Ostadsharif M, Nayeri H. [Study of vitamin D receptor gene TaqI polymorphism and its association with levels of gonadotropins and steroid hormones between obese women with polycystic ovarian syndrome and obese women in control group]. The Iranian Journal of Obstetrics, Gynecology and Infertility 2018; 21: 94–102. (in Persian)

[26] Hosseini AH, Kohan L, Aledavood A, Rostami S. Association of miR-146a rs2910164 and miR-222 rs2858060 polymorphisms with the risk of polycystic ovary syndrome in Iranian women: A case-control study. Taiwan J Obstet Gynecol 2017; 56: 652–656.

[27] Xue Y, Xu P, Xue K, Duan X, Cao J, Luan T, et al. Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis. Arch Gynecol Obstet 2017; 295: 487–496.

[28] Zˇofkova’ I, Zaj K, Hill M. Serum parathyroid hormone levels are associated with FokI polymorphism of the vitamin D receptor gene in untreated postmenopausal women. Eur J Intern Med 2003; 14: 232–236.

[29] Panidis D, Balaris C, Farmakiotis D, Rousso D, Kourtis A, Balaris V, et al. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 2005; 51: 1691–1697.

[30] Mahmoudi T, Gourabi H, Ashrafi M, Salman Yazdi R, Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010; 93: 1208– 1214.